Dual Actions of Ketorolac in Metastatic Ovarian Cancer

de réir Hudson, Laurie G., Cook, Linda S., Grimes, Martha M., Muller, Carolyn Y., Adams, Sarah F., Wandinger-Ness, Angela
Foilsithe / Cruthaithe 2019

The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo

de réir Grimes, Martha M., Kenney, S. Ray, Dominguez, Dayna R., Brayer, Kathryn J., Guo, Yuna, Wandinger-Ness, Angela, Hudson, Laurie G.
Foilsithe / Cruthaithe 2021

Agent-based modeling predicts RAC1 is critical for ovarian cancer metastasis

de réir Rivera, Melanie, Toledo-Jacobo, Leslie, Romero, Elsa, Oprea, Tudor I., Moses, Melanie E., Hudson, Laurie G., Wandinger-Ness, Angela, Grimes, Martha M.
Foilsithe / Cruthaithe 2022